Let's Talk Medtech: Kevin Sayer on Why all eyes are on Dexcom cover art

Let's Talk Medtech: Kevin Sayer on Why all eyes are on Dexcom

Let's Talk Medtech: Kevin Sayer on Why all eyes are on Dexcom

Listen for free

View show details

About this listen

 It's no secret that Dexcom is on the rise. From commercials during the Super Bowl, to blockbuster products on the horizon, the company is reaching a new height of popularity in the continuous glucose monitoring space. Kevin Sayer, Dexcom CEO, talks about the company's new position the space and all the hype surrounding the upcoming G7 CGM sensor. He also gives his thoughts on where CGM technology is headed in this incredible, can't miss conversation.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.